Pentas key facts
as of Oct 2026- Manufacturer of medical devices intended for treating cerebral vascular conditions.
- Pentas is valued at approximately $43.6M as of Oct 2026 (last reported valuation).
- It has raised $5.0M; the latest was Later Stage VC ($5.0M) in Sep 2025.
- Notable investors include XTech Ventures, WM PARTNERS (Tokyo), Fast Track Initiative, NES Venture Capital, Valueup Partners.
- Status: Privately Held (backing).
Pentas's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·Watch Pentas: the Monday email on marks, rounds and moves
Pentas funding rounds
No funding rounds for Pentas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pentas valuation
Pentas's last reported valuation was $43.6 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Pentas investors
5 investors are on record for Pentas, including XTech Ventures, WM PARTNERS (Tokyo), Fast Track Initiative and NES Venture Capital.
About Pentas
Manufacturer of medical devices intended for treating cerebral vascular conditions. The company's platform includes metal stents and specialized delivery microcatheters, along with preoperative simulation software designed to visualize and optimize stent placement, enabling the neuroendovascular therapy market to perform safer, more accurate procedures that improve patient outcomes and support effective stroke treatment.
- Sector
- Healthcare
- HQ
- Kawasaki, Japan
- Founded
- 2015
- Employees
- 10
- Website
- pentas-medical.jp/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.